Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -38.62x is 357% below its 5-year average of -8.45x, near the low end of its 5-year range (-38.62x–5.54x).
139352.57% below its 12-month average of -0.03x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.30x.
INTEREST COVERAGE RATIO
-38.62x
INTEREST COVERAGE RATIO AVG TTM
-0.03x
INTEREST COVERAGE RATIO AVG 3Y
-9.26x
INTEREST COVERAGE RATIO AVG 5Y
-8.45x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-139352.57%
CURRENT VS 3Y AVG
-317.19%
CURRENT VS 5Y AVG
-356.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.87x
median of 485 covered companies
CURRENT VS SECTOR MEDIAN
-557.92%
vs the sector median at left
Pulsenmore Ltd. Ordinary Shares
Market Cap
$14.57M
Interest Coverage Ratio
-38.62x
TTM Avg
-0.03x
3Y Avg
-9.26x
5Y Avg
-8.45x
Market Cap
$14.98M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.10M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.92M
Interest Coverage Ratio
-206.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.78M
Interest Coverage Ratio
-143.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.66M
Interest Coverage Ratio
-18.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.65M
Interest Coverage Ratio
-68.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $14.57M | -38.62x | -0.03x | -9.26x | -8.45x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.98M | N/A | N/A | N/A | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.10M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.92M | -206.17x | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.78M | -143.87x | N/A | N/A | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.25M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.66M | -18.73x | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.71M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.65M | -68.14x | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.78M | -1.98x | N/A | N/A | N/A |
Interest Coverage
-38.6x
Debt/Equity
0.71
Current Ratio
1.84
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.30x |
| 2025-12-31 | 5.54x |
| 2025-06-30 | -4.33x |
| 2024-06-30 | -29.18x |
| 2023-12-31 | -1.77x |
| 2023-06-30 | -24.51x |
| 2021-12-31 | -3.74x |
| 2021-06-30 | -8.35x |
